The world needs more Covid vaccines. Time to make some!
Even as the struggle against vaccine hesitancy and increasingly infectious variants continues, on a global level, demand for the vaccines that provide better immunity to Covid-19 has not been met.
One solution may be found in failure: CureVac, a German company that joined the rush of firms creating inoculants in 2020 found out in June that its product is only 47% effective against the coronavirus, compared to 90% or higher in vaccines made by Pfizer or Moderna.
Read the rest of this story on qz.com. Become a member to get unlimited access to Quartz’s journalism.
